Koning Health

Koning Corporation is revolutionizing the breast imaging industry with its advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. The company's vision is to fundamentally change breast cancer detection and diagnosis by providing earlier detection, increased patient comfort, and lower costs. With over 80 patents globally and regulatory approval in the US (FDA), Europe (CE-Mark), China (CFDA), Australia (TPG), and Canada (Health Canada), Koning Corporation has received over $17 M in venture funding and over $20 M in government grants to bring this groundbreaking technology to market. The company's last Equity Crowdfunding investment of $103.87K on 01 August 2022 further validates its promising trajectory. As Koning Corporation continues to develop its technology, it is expected to optimize early disease detection, diagnosis, intervention, and treatment in various areas of the body. Koning Corporation, founded in 2002 and based in the United States, holds great potential to improve survival rates and outcomes for millions of patients.